Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Immunity
|
December 15, 2021
Cytotoxic CD4<sup>+</sup> T cells in cancer: Expanding the immune effector toolbox
David Y Oh, Lawrence Fong
Immunity
|
December 20, 2018
Immunity in the Time of Metastases
David Y Oh, Lawrence Fong
Trends in Cancer
|
September 6, 2024
CD4<sup>+</sup> T cells in antitumor immunity
Elena Montauti, David Y Oh, Lawrence Fong
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2015
On the Verge: Immunotherapy for Colorectal Carcinoma
David Y Oh, Alan P Venook, Lawrence Fong
Methods in Molecular Biology (Clifton, N.J.)
|
November 27, 2021
Preparation of Radiolabeled Antibodies for Nuclear Medicine Applications in Immuno-Oncology
Junnian Wei, David Y Oh, Michael J Evans
Nature Immunology
|
January 18, 2005
Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment
Nirav R Bhakta, David Y Oh, Richard S Lewis
Clinical Science (London, England : 1979)
|
March 9, 2021
Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors
Alan H Baik, Katy K Tsai, David Y Oh, et al.
Cell
|
March 12, 2003
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor
Zusen Fan, Paul J Beresford, David Y Oh, et al.
Immunity
|
December 8, 2009
Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes
Lauren I Richie Ehrlich, David Y Oh, Irving L Weissman, et al.
Oncoimmunology
|
December 15, 2018
Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer
Katsunobu Hagihara, Stephen Chan, Li Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Immunity
|
December 15, 2021
Cytotoxic CD4<sup>+</sup> T cells in cancer: Expanding the immune effector toolbox
David Y Oh, Lawrence Fong
Immunity
|
December 20, 2018
Immunity in the Time of Metastases
David Y Oh, Lawrence Fong
Trends in Cancer
|
September 6, 2024
CD4<sup>+</sup> T cells in antitumor immunity
Elena Montauti, David Y Oh, Lawrence Fong
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2015
On the Verge: Immunotherapy for Colorectal Carcinoma
David Y Oh, Alan P Venook, Lawrence Fong
Methods in Molecular Biology (Clifton, N.J.)
|
November 27, 2021
Preparation of Radiolabeled Antibodies for Nuclear Medicine Applications in Immuno-Oncology
Junnian Wei, David Y Oh, Michael J Evans
Nature Immunology
|
January 18, 2005
Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment
Nirav R Bhakta, David Y Oh, Richard S Lewis
Clinical Science (London, England : 1979)
|
March 9, 2021
Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors
Alan H Baik, Katy K Tsai, David Y Oh, et al.
Cell
|
March 12, 2003
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor
Zusen Fan, Paul J Beresford, David Y Oh, et al.
Immunity
|
December 8, 2009
Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes
Lauren I Richie Ehrlich, David Y Oh, Irving L Weissman, et al.
Oncoimmunology
|
December 15, 2018
Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer
Katsunobu Hagihara, Stephen Chan, Li Zhang, et al.
Page
of 4